HFA Premium Access

Prognostic importance of changes in 6-min walk test during titration of pharmacotherapy in HFrEF

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Peder Langeland Myhre

Akershus University Hospital, Nordbyhagen (Norway)
2 presentations
0 follower

6 more presentations in this session

Gender difference and clinical course of atrial fibrillation in patients with non-ischaemic cardiomyopathy

Speaker: Doctor I. Chung (Singapore, SG)

Thumbnail

The relationship between the right ventricular function, cardiac catheterization and CPET parameters in patients with advanced heart failure

Speaker: Professor R. Acar (Istanbul, TR)

Thumbnail

Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH

Speaker: Doctor C. Paitazoglou (Luebeck, DE)

Thumbnail

The first audit in real-world titration pattern of maximisation of four pillars of heart failure therapy to target doses in Irish nurse-led clinics.

Speaker: Ms C. Murphy (Wexford, IE)

Thumbnail

Impact of heart failure evidence-based-therapy in hypotensive patients

Speaker: Doctor A. Fonseca (Porto, PT)

Thumbnail

Access the full session

Heart failure with reduced ejection fraction (HFrEF) 3

Speakers: Doctor P. Myhre, Doctor I. Chung, Professor R. Acar, Doctor C. Paitazoglou, Ms C. Murphy...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb